These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21115010)

  • 1. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.
    Chan AT; Ogino S; Giovannucci EL; Fuchs CS
    Gastroenterology; 2011 Mar; 140(3):799-808, quiz e11. PubMed ID: 21115010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma inflammatory biomarkers and modifiable lifestyle factors associated with colorectal cancer risk.
    Kim J; Lee J; Oh JH; Chang HJ; Sohn DK; Shin A; Kim J
    Clin Nutr; 2020 Sep; 39(9):2778-2785. PubMed ID: 31883943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.
    Din FV; Theodoratou E; Farrington SM; Tenesa A; Barnetson RA; Cetnarskyj R; Stark L; Porteous ME; Campbell H; Dunlop MG
    Gut; 2010 Dec; 59(12):1670-9. PubMed ID: 20844293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of plasma inflammatory markers and risk of colorectal cancer in men.
    Song M; Wu K; Ogino S; Fuchs CS; Giovannucci EL; Chan AT
    Br J Cancer; 2013 May; 108(9):1891-8. PubMed ID: 23591192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer.
    Mehta RS; Song M; Bezawada N; Wu K; Garcia-Albeniz X; Morikawa T; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
    J Natl Cancer Inst; 2014 Apr; 106(4):dju016. PubMed ID: 24565956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
    Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
    JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer after start of nonsteroidal anti-inflammatory drug use.
    Stürmer T; Buring JE; Lee IM; Kurth T; Gaziano JM; Glynn RJ
    Am J Med; 2006 Jun; 119(6):494-502. PubMed ID: 16750963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
    Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?
    Burr NE; Hull MA; Subramanian V
    World J Gastroenterol; 2016 Apr; 22(13):3679-86. PubMed ID: 27053860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.
    Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
    Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs but not aspirin are associated with a lower risk of post-colonoscopy colorectal cancer.
    Cheung KS; Chen L; Chan EW; Seto WK; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2020 May; 51(9):899-908. PubMed ID: 32201976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
    Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.
    González-Pérez A; García Rodríguez LA; López-Ridaura R
    BMC Cancer; 2003 Oct; 3():28. PubMed ID: 14588079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice.
    Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA
    PLoS One; 2016; 11(7):e0159179. PubMed ID: 27428004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.
    Ho GY; Xue X; Cushman M; McKeown-Eyssen G; Sandler RS; Ahnen DJ; Barry EL; Saibil F; Bresalier RS; Rohan TE; Baron JA
    J Natl Cancer Inst; 2009 Dec; 101(23):1650-4. PubMed ID: 19822838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based case-control study: chemoprotection of colorectal cancer with non-aspirin nonsteroidal anti-inflammatory drugs and other drugs for pain control.
    Rodríguez-Miguel A; García-Rodríguez LA; Gil M; Barreira-Hernández D; Rodríguez-Martín S; de Abajo FJ
    Aliment Pharmacol Ther; 2019 Aug; 50(3):295-305. PubMed ID: 31313358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
    Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
    Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesalamine protects against colorectal cancer in inflammatory bowel disease.
    Tang J; Sharif O; Pai C; Silverman AL
    Dig Dis Sci; 2010 Jun; 55(6):1696-703. PubMed ID: 19705280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.